Page 35 - Associate Chief News Today : Breaking News, Live Updates & Top Stories | Vimarsana

John J. Pershing VA Medical Center prepares for COVID-19 vaccine arrival John J. Pershing VA Medical Center prepares for COVID-19 vaccine arrival By Isabelle Hanson | December 17, 2020 at 4:50 PM CST - Updated December 18 at 4:41 AM POPLAR BLUFF, Mo. (KFVS) - Healthcare workers at John J. Pershing VA Medical Center could receive their first shipment of COVID-19 vaccines as early as Tuesday, December 22. “I think there’s gonna be a lot of relief once this Moderna vaccine is approved and we are ready to go,” said Bailey Wells, John J. Pershing VA Medical Center chief nurse for Specia...

Now Announcing: The Ai4 2021 Cybersecurity Summit Speaker Lineup The fully-digital Ai4 2021 Cybersecurity Summit will gather 50+ speakers from the world's most innovative companies. NEW YORK, NEW YORK, USA, December 15, 2020 /EINPresswire.com/ -- The fully-digital Ai4 2021 Cybersecurity Summit will gather 50+ speakers from the world's most innovative companies on February 3-4, 2021. With over 40 hours of content across 4 tracks it’s too much for any one person to experience, but attendees will be able to personalize their agendas to ensure they learn ...

(1) Agendia and Roche evaluate BluePrint's stratification of HER2+ early breast cancer patients treated with adjuvant pertuzumab Agendia, Inc., a world leader in precision oncology for breast cancer, today announced data from the APHINITY trial in a poster spotlight discussion at the 2020 San Antonio Breast Cancer Symposium (SABCS 2020). The poster, titled Prediction of benefit from adjuvant pertuzumab by BluePrint RNA sequencing in the APHINITY trial, outlines data from an exploratory analysis of the Phase 3 study that randomized 4,805 patients with histologically centrally confirmed HE...